 |
Trucode
Last updated: October 09, 2024
CEO Marshall Fordyce
USA | Funding: $34M (+)
Website: https://www.trucode.com/
Trucode develops gene editing assets designed to correct the mutations behind diseases including sickle cell and cystic fibrosis.
Website: https://www.trucode.com/
Trucode develops gene editing assets designed to correct the mutations behind diseases including sickle cell and cystic fibrosis.
